CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo
Vitiligo is an autoimmune disease of the skin that results in disfiguring white spots. There are
no US Food and Drug Administration–approved treatments for vitiligo, and most off-label …
no US Food and Drug Administration–approved treatments for vitiligo, and most off-label …
CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.
M Rashighi, P Agarwal, JM Richmond… - Science Translational …, 2014 - europepmc.org
Vitiligo is an autoimmune disease of the skin that results in disfiguring white spots. There are
no FDA-approved treatments for vitiligo, and most off-label treatments yield unsatisfactory …
no FDA-approved treatments for vitiligo, and most off-label treatments yield unsatisfactory …
[引用][C] CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
M Rashighi, P Agarwal, JM Richmond… - Science Translational …, 2014 - cir.nii.ac.jp
CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model
of Vitiligo | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
of Vitiligo | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo
M Rashighi, P Agarwal… - Science …, 2014 - pubmed.ncbi.nlm.nih.gov
Vitiligo is an autoimmune disease of the skin that results in disfiguring white spots. There are
no US Food and Drug Administration-approved treatments for vitiligo, and most off-label …
no US Food and Drug Administration-approved treatments for vitiligo, and most off-label …
[PDF][PDF] CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
M Rashighi, P Agarwal, JM Richmond, TH Harris… - researchgate.net
Vitiligo is an autoimmune disease of the skin that results in disfiguring white spots. There are
no US Food and Drug Administration–approved treatments for vitiligo, and most off-label …
no US Food and Drug Administration–approved treatments for vitiligo, and most off-label …
[HTML][HTML] CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo
M Rashighi, P Agarwal, JM Richmond… - Science translational …, 2014 - ncbi.nlm.nih.gov
Vitiligo is an autoimmune disease of the skin that results in disfiguring white spots. There are
no FDA-approved treatments for vitiligo, and most off-label treatments yield unsatisfactory …
no FDA-approved treatments for vitiligo, and most off-label treatments yield unsatisfactory …
CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo
M Rashighi, P Agarwal, JM Richmond… - 2014 - repository.escholarship.umassmed …
Vitiligo is an autoimmune disease of the skin that results in disfiguring white spots. There are
no US Food and Drug Administration-approved treatments for vitiligo, and most off-label …
no US Food and Drug Administration-approved treatments for vitiligo, and most off-label …
CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.
M Rashighi, P Agarwal, JM Richmond… - Science Translational …, 2014 - europepmc.org
Vitiligo is an autoimmune disease of the skin that results in disfiguring white spots. There are
no FDA-approved treatments for vitiligo, and most off-label treatments yield unsatisfactory …
no FDA-approved treatments for vitiligo, and most off-label treatments yield unsatisfactory …